Evidence map›Paper›PMID 31197199›Full record

ArticleScientific reports2019

Binding and Flip as Initial Steps for BP-100 Antimicrobial Actions.

Peter Park, Leandro R Franco, Hernan Chaimovich, Kaline Coutinho, Iolanda M Cuccovia, Filipe S Lima

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. A MarineMarine drugs · 2026
    Article
  2. Article
  3. Article
  4. Deciphering the Mechanism of Action of the Antimicrobial Peptide BP100.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Peter ParkDepartamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0001-5671-9354
Leandro R FrancoDepartamento de Física Geral, Instituto de Física, Universidade de São Paulo, São Paulo, Brazil.
Hernan ChaimovichDepartamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0001-9380-2157
Kaline CoutinhoDepartamento de Física Geral, Instituto de Física, Universidade de São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-7586-3324
Iolanda M CuccoviaDepartamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, Brazil. imcuccov@iq.usp.br.
Filipe S LimaDepartamento de Química Fundamental, Centro de Ciências Exatas e da Natureza, Universidade Federal de Pernambuco, Recife, Brazil. filipe.lima@usp.br.ORCID http://orcid.org/0000-0002-3420-8155

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BP100 is a short antimicrobial peptide and can also act as a molecule-carrier into cells. Like with other antimicrobial peptides, the precise mechanism of membrane disruption is not fully understood. Here we use computer simulations to understand, at a molecular level, the initial interaction between BP100 and zwitterionic/negatively charged model membranes. In agreement with experimental results, our simulations showed BP100 folded into an alpha helix when in contact with negatively charged membranes. BP100 binding induced the aggregation of negatively charged lipids on mixed membranes composed of zwitterionic and anionic lipids. The peptide in alpha-helix conformation initially interacts with the membrane via electrostatic interactions between the negatively charged lipids and the positively charged residues of the peptide. At that point the peptide flips, burying the hydrophobic residues into the bilayer highlighting the importance of the hydrophobic effect contribution to the initial interaction of cationic antimicrobial peptides with membranes.

Indexed as

1,2-DipalmitoylphosphatidylcholineAnti-Infective AgentsLipid BilayersMolecular Dynamics SimulationOligopeptidesPhosphatidylglycerolsProtein Structure, SecondaryWater1,2-Dipalmitoylphosphatidylcholine1,2-dipalmitoylphosphatidylglycerolAnti-Infective AgentsLipid Bilayerslysyl-lysyl-leucyl-phenylalanyl-lysyl-lysyl-isoleucyl-leucyl-lysyl-tyrosyl-leucinamideOligopeptidesPhosphatidylglycerolsWater

Identifiers

PMID31197199
PMCPMC6565725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.